The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Ent.it. Regulatory News (DNE)

Share Price Information for Dunedin Ent.it. (DNE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 484.00
Bid: 468.00
Ask: 500.00
Change: 0.00 (0.00%)
Spread: 32.00 (6.838%)
Open: 484.00
High: 0.00
Low: 0.00
Prev. Close: 484.00
DNE Live PriceLast checked at -
Dunedin Enterprise is an Investment Trust

To conduct an orderly realisation of its assets, to be effected in a manner that seeks to achieve a balance between maximising the value of the investments and progressively returning cash to Shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3rd Quarter Results

16 Nov 2016 13:14

RNS Number : 3605P
Dunedin Enterprise Inv Trust PLC
16 November 2016
 

Dunedin Enterprise Investment Trust PLC (Company No SC52844) - Quarterly Update

 

Whilst there is no longer a requirement to publish an Interim Management Statement ("IMS") the Board of Dunedin Enterprise Investment Trust PLC ("Dunedin Enterprise") has decided to continue to provide an update on the net asset value of the Trust in a similar format as previously provided in the IMS on a quarterly basis. This net asset value update is as at 30 September 2016.

 

1. Unaudited net asset value per share

 

The unaudited net asset value per share at 30 September 2016 was 473.0p. This represents a decrease of 0.6% from the level at 30 June 2016.

 

2. Share price

 

The share price has increased by 5.2% from 310.0p to 326.0p in the quarter to 30 September 2016. This compares to an increase in the FTSE Small Cap Index of 11.9% over the same period. The discount to net asset value at 30 September 2016 was 31%.

 

3. Balance Sheet

 

The unaudited balance sheet as at 30 September 2016 is noted below:-

 

£'m

Investments:-

Dunedin managed

73.8

Third party managed

21.8

95.6

Cash and near cash

1.6

Other assets and liabilities

0.5

Total net assets

97.7

 

 

Net asset value per share (p)

473.0p

 

4. Net asset value movements

 

The portfolio of investments has been re-valued at 30 September 2016. The decrease in net asset value in the quarter can be attributed to:-

 

· Within the Dunedin managed portfolio there were valuation increases at Blackrock (£1.1m) and Kee Safety (£0.6m). Blackrock continues to show strong organic earnings growth. Kee Safety has now completed ten acquisitions under Dunedin's ownership. The maintainable earnings of Kee Safety have benefitted from both organic growth and a contribution from these ten acquisitions

· The valuation of the two European funds (Innova - £1.0m, Realza - £0.6m) have both benefited from favourable exchange rate movements. In addition Innova also benefited from valuation increases from portfolio companies operating in the food and building products sectors.

· These valuation uplifts have been offset principally by reductions in value at Hawksford (£2.8m).and Formaplex (£0.7m). At both Hawksford and Formaplex there has been uncertainty due to significant management change over the past six months. Both companies now have new leadership in place.

· Management fees and banking costs contributed a reduction in net assets of £0.6m.

 

5. New investment and realisations

 

A further investment of £0.3m was made in EV to support working capital.

 

A total of £5.7m was realised from portfolio companies during the quarter. Both Kee Safety and U-POL successfully completed re-financings. Kee Safety redeemed £1.1m of loan stock and paid £1.8m of accrued loan interest. U-POL paid £2.6m of accrued interest.

 

6. Cash and Commitments

 

The Company had cash and near cash balances of £1.6m at 30 September 2016. In addition the Company has a revolving credit facility of £20m available until 31 May 2018.

 

As at 30 September 2016 the Company has outstanding capital commitments to limited partnership funds of £37.0m of which it is forecast that approximately up to £20m will be drawn over the next three years.

 

The Board and Manager remain satisfied with the balance between available credit facilities and outstanding commitments given the expected rate of new investment and potential realisations of existing investments.

 

7. Outlook

 

The UK economy and M&A market continues to be affected by the economic uncertainty, the oil price weakness and the impact of the Brexit vote. Trading in portfolio companies continues to be mixed.

 

 

 

For further information on Dunedin Enterprise please go to www.dunedinenterprise.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMMMMMFVGGVZM
Date   Source Headline
22nd Mar 20247:00 amRNSAnnual Financial Report
5th Feb 20241:58 pmRNSHolding(s) in Company
5th Feb 20241:56 pmRNSHolding(s) in Company
5th Feb 20241:54 pmRNSHolding(s) in Company
1st Feb 20247:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/23
19th Dec 20232:34 pmRNSHolding(s) in Company
19th Dec 20232:22 pmRNSHolding(s) in Company
13th Dec 20237:00 amRNSDividend Declaration
21st Nov 20237:00 amRNSPremier Hytemp realisation & potential winding-up
16th Nov 20237:00 amRNS3rd Quarter Results
6th Nov 20234:33 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSPortfolio Update
1st Nov 20237:00 amRNSPreliminary Unaudited Net Asset Value at 30/9/23
28th Sep 20237:00 amRNSPortfolio Update
15th Sep 20237:00 amRNSHalf-year Report
1st Aug 20237:00 amRNSPreliminary unaudited net asset value at 30/6/23
6th Jun 20239:01 amRNSHolding(s) in Company
22nd May 202310:05 amRNSHolding(s) in Company
10th May 20232:42 pmRNSResult of AGM
10th May 20232:42 pmRNS1st Quarter Results
2nd May 20237:00 amRNSPreliminary unaudited net asset value at 31/3/23
24th Mar 20237:00 amRNSAnnual Financial Report
1st Feb 20237:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/22
7th Dec 20221:02 pmRNSDirector/PDMR Shareholding
7th Dec 20221:00 pmRNSDirector/PDMR Shareholding
7th Dec 20221:00 pmRNSDirector/PDMR Shareholding
6th Dec 202211:12 amRNSDirector/PDMR Shareholding
6th Dec 202211:09 amRNSDirector/PDMR Shareholding
1st Dec 202212:42 pmRNSHolding(s) in Company
30th Nov 20225:50 pmRNSDirector/PDMR Shareholding
30th Nov 20225:48 pmRNSDirector/PDMR Shareholding
30th Nov 202212:10 pmRNSHolding(s) in Company
29th Nov 20225:25 pmRNSHolding(s) in Company
29th Nov 202210:42 amRNSHolding(s) in Company
28th Nov 20229:06 amRNSHolding(s) in Company
25th Nov 20222:32 pmRNSHolding(s) in Company
22nd Nov 20227:00 amRNSResult of Tender Offer
16th Nov 202212:52 pmRNS3rd Quarter Results
16th Nov 202212:49 pmRNSResult of General Meeting
4th Nov 202210:00 amRNSHolding(s) in Company
4th Nov 20228:51 amRNSHolding(s) in Company
1st Nov 20227:00 amRNSQ3 Preliminary NAV and Tender Offer Price
21st Oct 20227:00 amRNSInterim Dividend
21st Oct 20227:00 amRNSTender Offer
7th Oct 20227:00 amRNSPortfolio Update
16th Sep 20227:00 amRNSHalf-year Report
25th Aug 20229:15 amRNSPortfolio Update
1st Aug 20227:00 amRNSPreliminary unaudited net asset value at 30/6/22
11th May 20222:58 pmRNSResult of AGM
11th May 20221:26 pmRNS1st Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.